The new label for Ozempic is based on the results of the FLOW trial, which showed a statistically significant reduction in kidney disease progression, as well as cardiovascular and kidney death with a 1 mg/kg weekly dose of the injectable drug compared to placebo
The best places to give the injection are the upper arms, stomach, or upper legs
Sergey Terushkin, MD, FACS Last Updated: April 30, 2026 If your weight loss has slowed or stopped on semaglutide, youre not aloneplateaus are a normal biological response
These conditions are closely linked and substantially increase the risk of cardiovascular disease, stroke, chronic kidney disease, neuropathy, retinopathy, and premature mortality
Increasing evidence has demonstrated that GLP-1 analogues can cross the blood-brain barrier, protect dopaminergic neurons in the substantia nigra, and rescue motor activity and cognitive functions in PD animal models (5961)